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Background: Although sickle cell disease (SCD) children are highly susceptible to bacterial infections (BIs), there is a
dreadful lack of data related to the burden and spectrum of BIs in sub-Saharan Africa (SSA), the highest affected
region with SCD. This study aimed to determine the burden and spectrum of BIs among SCD children hospitalized
in a pediatric reference hospital in Cameroon, a SSA country.
Methods: We conducted a retrospective analysis of records of children hospitalized from November 2012 to
August 2015 in the SCD unit of the Mother and Child Centre of the Chantal Biya Foundation, Cameroon. We
enrolled all known SCD children aged 15 years or less, hospitalized for a suspicion of BI and who presented a
positive culture of a body specimen.
Results: A total of 987 SCD children were hospitalized during the study period. Cultures were positive for 96 patients
(9.7%) among whom 60.4% males. Ages ranged from 6 to 192 months with a median of 53 (Interquartile range (IQR)
21–101) months. For children no more covered by the Expanded Programme on Immunization, only 13 (18.8%) had
received the Pneumo 23® and Meningo A&C® antigens, and 12 (17.4%), the Typhim vi® and the Haemophilus influenzae
type b antigens; 58 children (84.1%) had received no vaccine. The specimen yielding positive cultures were: blood (70.
7%), urine (13.1%), pus (9.1%), synovial fluid (4.1%), cerebrospinal fluid (2.0%), and bone fragment (1.0%). The different
types of infection included: urinary tract infections (13.5%), myositis (8.3%), arthritis (6.3%), osteomyelitis (4.2%), and
meningitis (2.1%); the site of infection was unidentified in 65.6% of cases. The main bacteria included: Salmonella sp.
(28.1%), Staphylococcus sp. (18.8%), Klebsiella pneumoniae (17.7%), Escherichia coli (10.4%), Enterobacter sp. (5.2%),
Acinetobacter sp. (4.2%), Streptococcus sp. (4.2%) and Serratia sp. (4.2%).
Conclusion: This retrospective analysis revealed 9.7% cases of BIs, mainly caused by Salmonella sp. (28.1%),
Staphylococcus sp. (18.8%), Klebsiella pneumoniae (17.7%), and Escherichia coli (10.4%).
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Sickle Cell disease (SCD) also referred to as Sickle Cell
Anemia, is the most widespread and severe monogenetic
disorder in the world, specifically in Africa south of the
Sahara where it constitutes a real public health issue
with 1–4% of babies born affected [1–3]. In Cameroon,* Correspondence: jobertrichie_nansseu@yahoo.fr
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[4], and the disease prevalence is estimated at 0.6% in
the general population. It is estimated that almost 4000
babies will be born with a major sickle cell syndrome
each year (unpublished data).
SCD is particularly disastrous, mainly due to its acute
and chronic complications, including painful vaso-
occlusive events, cerebral vasculopathy, priapism, chronic
kidney disease, acute chest syndrome, pulmonary hyper-
tension and bacterial infections (BIs) among others [5–7].
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tion. As such, they constitute a major cause of morbidity
and mortality among SCD children and adults [8, 9]. A
20-years prospective study showed for instance that BIs
led to 20–50% of deaths among SCD patients [8]. The
increased susceptibility of SCD patients to BIs is multi-
factorial, including: (i) a functional asplenia; (ii) a default
in complement activation; (iii) micronutrient deficiencies;
(iv) a genetic predisposition, and (v) mechanical risk
factors [8].
The organisms most commonly isolated from children
with SCD are: Streptococcus pneumoniae, non-typhi Sal-
monella sp., Haemophilus influenzae type b, Escherichia
coli, Acinetobacter sp. and Klebsiella sp. [10, 11]. Evidence
accumulated indicates a strong association between SCD
and invasive bacterial disease among SCD Africans, es-
pecially greater for Streptococcus pneumoniae, non-
typhi Salmonella sp. and Haemophilus influenzae type
b [11, 12]. Moreover, it has been claimed a predominance
of invasive pneumococcal infections below the age of five,
and salmonella infections above 5 years old [13, 14].
While sub-Saharan Africa (SSA) is the highest affected
region with SCD, there is a paradoxical dearth of data
regarding the spectrum of BIs among SCD patients to
guide the proper and efficient management of these
threats across the region, especially in Cameroon, a SSA
country. Willing to fill this critical gap, the present study
was undertaken, the aim of which was to assess the bur-
den and spectrum of BIs which have occurred among
SCD children hospitalized in a pediatric reference hos-
pital in Cameroon.
Methods
Study design and setting
We conducted a retrospective analysis of records of
children hospitalized in the SCD unit of the Mother
and Child Centre of the Chantal Biya Foundation from
November 2012 to August 2015. This Centre, which
has been well described elsewhere [7], is a pediatric ref-
erence hospital receiving patients coming from all over
the country and the rest of the Central African sub-
region. Nearly 700 SCD patients are regularly followed-
up, with an average of 400 hospitalizations per year.
The body specimens were analyzed at the Centre Pasteur
of Cameroon. Located in Yaoundé and at a 2-min walking
distance from the hospital, the Centre Pasteur of
Cameroon is the laboratory of reference in the country;
it uses international standard procedures and goes along a
regular and rigorous internal and external control of
quality.
Study participants
During the study period, we consecutively and exhaust-
ively included all known SCD children aged 15 years orless, who have been hospitalized for a suspicion of BI
and presented a positive result after culture of a body
specimen (blood, urine, cerebrospinal fluid, bone fragment,
synovial fluid or pus). Samples were collected in the unit
and transported without delay to the Centre Pasteur of
Cameroon where they were analyzed. Bacterial isolations
were conducted using standard culture milieus such as
Cystine Lactose Electrolyte Deficient, Chapman, Mac
Conkey, chocolate (agar cooked/fresh blood), or polyvitex
chocolate, depending on the type of specimen to be ana-
lyzed. Identification of the bacteria used different specific
antibiotic galleries. Poly-microbial cultures were not con-
sidered in the present work, neither were contaminations
(identified as positive cultures in patients with fever drop-
ping without any antibiotherapy, or good remission with
an antibiotherapy described, after the antibiogram, as re-
sistant to the incriminated bacterium).Data collection
We used a preconceived and standardized questionnaire
for data abstraction. Data were collected on age, sex,
vaccination status after the Expanded Programme on
Immunization (EPI) (especially regarding Pneumo 23®,
Meningo A&C®, Haemophilus influenzae type b and
Typhim vi® antigens), clinical signs and symptoms at
presentation (fever, vaso-occlusive crises), site of infec-
tion and type of sampling performed, isolated bacterium,
treatment and outcome in the course of hospitalization.Statistical methods
Data were coded and entered using Microsoft Excel
2010, and analyzed with SPSS software version 20.0
(IBM SPSS Inc., Chicago, Illinois, USA). Results are pre-
sented as frequency (percentage) for qualitative variables,
and median (interquartile range (IQR)) for quantitative
ones. Comparison between qualitative variables used the
Chi-2 test, and results were considered statistically signifi-
cant when p < 0.05.Ethical statement
Before commencing this study, authorizations were ob-
tained from administrative authorities of the Mother and
Child Centre, and an ethical clearance was granted by its
Ethical Review Board. All the procedures used in the
present study were in keeping with the current revision
of the Helsinki Declaration. As the study was retrospect-
ive, patients’ consents could not be obtained. However,
the study was approved by the association of parents of
SCD children of the Mother and Child Centre which in-
cludes the majority of parents of these diseased children
formerly followed-up or hospitalized in the SCD unit.
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On the whole, 987 children suffering from SCD were hos-
pitalized during the study period; cultures were positive for
96 patients (9.7%). Patients’ ages ranged from 6 to
192 months, with a median of 53 (IQR 21–101) months.
There were 58 males (60.4%), hence a M/F sex ratio of
1.53/1. Twenty seven children (28.1%) were aged less than
24 months (Table 1). Among the 69 patients equal or
above 24 months of age, only a few had received vaccine
recalls after the EPI: 13 (18.8%) for the Pneumo 23® and
Meningo A&C® antigens, and 12 (17.4%) for the Typhim
vi® and the Haemophilus influenzae type b antigens; 58Table 1 Demographic characteristics, main symptoms and sites
of infection
Characteristic Number Percentage (%)
Age groups (years)
< 2 27 28.1





EPI (0 to 12 months) 96 100.0
Overall coverage from 24 months (N = 69) 11 15.9
Pneumo 23 (N = 69) 13 18.8
Meningo A&C (N = 69) 13 18.8
Typhim vi (N = 69) 12 17.4
Haemophilus influenzae type b (N = 69) 12 17.4
Vaso-occlusive crises: yes/missing 80/07 83.3/7.3










Blood + synovial fluid 01 1.0
Blood + bone fragment 01 1.0
Blood + pus 02 2.1
Pus 07 7.3
Cerebrospinal fluid 02 2.1
Urine 13 13.6
Synovial fluid 03 3.1
EPI Expanded Programme on Immunization; aTotal: 99 specimen sampled
for culturechildren (84.1%) had received no vaccine (Table 1). Fever
was noticed among 90 patients (93.5%), and vaso-occlusive
crises were present among 80 children (83.3%; Table 1).
The specimen yielding positive cultures were: blood
(70.7%), urine (13.1%), pus (9.1%), synovial fluid (4.1%),
cerebrospinal fluid (2.0%), and bone fragment (1.0%).
The different types of infection were: urinary tract infec-
tions (13.5%), myositis (8.3%), arthritis (6.3%), osteomye-
litis (4.2%), and meningitis (2.1%). Besides, the site of
infection was unidentified (bacterial septicemia) in 63
patients (65.6%; Table 1). There was no difference be-
tween males and females (p = 0.779), and between the
under-5 and 5+ years old (p = 0.291) with regard to the
type of infection.
Bacteria were Gram negative in 74 cases (77.1%), with
no difference between males and females (p = 0.396),
and the under-5 and 5+ years (p = 0.221). Table 2 is rep-
resentative of the different bacteria recorded with regard
to the type of infection presented. The main bacteria in-
cluded: Salmonella sp. (28.1%), Staphylococcus sp.
(18.8%), Klebsiella pneumoniae (17.7%), Escherichia coli
(10.4%), Enterobacter sp. (5.2%), Acinetobacter sp. (4.2%),
Streptococcus sp. (4.2%), and Serratia sp. (4.2%). The ma-
jority of cases of septicemias were caused by Staphylo-
coccus sp. (24.6%), Salmonella sp. (24.6%) and Klebsiella
pneumoniae (16.9%). Escherichia coli was responsible for
the majority of cases of urinary tract infections (53.8%)
and Salmonella sp., for all cases of myositis, The two
cases of meningitis were caused by Streptococcus pneu-
moniae (Table 2). Moreover, five patients presented an
infectious recurrence; the most common bacterium in
cause was Staphylococcus sp., and the site of infection
was not identified in the majority of cases (Table 3).
Noteworthy, the antibiotherapy, which was started
after the sampling had been done and before waiting for
bacteriological results, comprised: as first line ceftriaxone
and gentamycin, and as second line ofloxacin/ciprofloxacin
and amikacin (or licomycin, depending on the results of
the antibiogram as soon as available). The outcome was
favorable for 82 patients (85.4%), but worse for the
other ones among whom 4 patients ending up with
osteo-articular sequelae (4.2%); 7 patients (7.3%) were
transferred to undergo surgery (for osteomyelitis or
myositis), and 3 patients (3.1%) died. Duration of
hospitalization in the SCD unit varied between 1 and
21 days with a median of 9 (IQR 8–12) days.
Discussion
Bacterial infections (BIs) are a major cause of morbidity
and mortality among SCD children and adults [8], but
there remains a crucial dearth of data regarding its bur-
den in SSA countries such as Cameroon. We aimed to
assess the burden and spectrum of BIs in our context.
Results from the present retrospective analysis showed a
Table 2 Different germs recorded considering the type of infection
Germ Type of infection Total
Myositis Osteomyelitis Arthritis Urinary tract infection Meningitis Septicemia
Acinetobacter baumanii 3 03
Acinetobacter (others) 1 01
Alloiococcus otitidis 1 01
Citrobacter koserii 1 01
Corynebacterium sp. 1 01
Enterobacter aerogenes 1 01
Enterobacter cloacae 1 3 04
Enterococcus sp 1 01
Escherichia coli 7 3 10
Klebsiella pneumoniae 2 4 11 17
Proteus mirabilis 1 01
Proteus vulgaris 1 01
Pseudomonas fluorescens 1 01
Salmonella dublin 1 1 02
Salmonella enterica serovar stanleyville 1 1 02
Salmonella enteritidis 2 3 05
Salmonella sp. (others) 5 1 1 9 16
Salmonella typhi 1 1 02
Serratia liquefaciens 1 01
Serratia marcescens 3 03
Staphylococcus aureus 1 1 02
Staphylococcus epidermidis 4 04
Staphylococcus haemolyticus 4 04
Staphylococcus hominis 6 06
Staphylococcus sciuri 1 01
Staphylococcus (others) 1 01
Streptococcus pneumoniae 2 02
Streptococcus of group C 1 01
Streptococcus (others) 1 01
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by Williams et al. [11]. On the contrary, our findings are
lower that what were observed by Diop et al. [15] and
Diakité et al. [16], respectively 50% and 40%. This low
prevalence (9.7%) could be explained by the fact that
due to lack of financial means, many patients’ parentsTable 3 Cases of infectious recurrence
Patient First episode
Age (months) Germ Type of infection
1 11 Staphylococcus sciuri Septicemia
2 52 Salmonella sp Septicemia
3 123 Staphylococcus sp Septicemia
4 159 Enterobacter cloaccae Arthritis
5 17 Escherichia coli Urinary tract infectionwere incapable of doing all the required exams. We no-
ticed for instance that only 46.2% of the bacteriological
tests required were performed. Furthermore and in the
large majority of cases, only one blood culture (instead
of at least three per patient) was performed, lowering
therefore our probability of catching up the bacterium.Second episode
Age (months) Germ Type of infection
21 Staphylococcus haemolyticus Septicemia
75 Staphylococcus hominis Septicemia
133 Enterobacter cloaccae Septicemia
170 Corynebacterium sp Septicemia
28 Escherichia coli Urinary tract infection
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borns are not systematically screened for SCD. In this
study we considered only known SCD patients, which
could have underestimated the real burden of BIs in this
vulnerable population.
In Cameroon indeed, newborn hemoglobinopathy test-
ing is neither available nor implemented universally com-
pared to developed countries. Only parents of SCD
children who are being followed in specialized centers will
be educated and counselled on infection prophylaxis with
oral penicillin (to be paid by the parent), and to bring
their children to the hospital when the temperature
rises. Since 2011, the Prevenar 13® vaccine was intro-
duced in the Cameroon Expanded Programme on
Immunization, which is administered free of charge to
all children at 6, 10 and 14 weeks of age. Additionally, a
23-valent pneumococcal vaccine as well as some others
(Typhim vi, Meningo A&C) are proposed at 24 months
to SCD children who are followed-up, but it is not
given free of charge; hence only parents who can afford
will vaccinate their kids.
This explains perhaps why we observed in this study, a
low vaccination coverage after the EPI, around 15.9%.
Similarly, previous African reports have bolstered a low
vaccination coverage after the EPI in the young pediatric
population, around 6.2–32.5% in the Gabonese public
sector with pneumococcal antigen coverage equaling
0.8%, and around 10.8–13% in Cameroon [17, 18]. It is
worth mentioning that our SCD children’s parents are
always sensitized and educated on the importance of
vaccinating their vulnerable kids and reminded in this
regard, with regular campaigns being organized by the
association of parents of SCD children. However, the costs
of vaccines remain high for a large majority of parents,
perhaps justifying the low coverages we have witnessed.
Subsidization of vaccinations could thereby constitute a
valuable solution to increase the vaccination coverage in
this group of children. Nevertheless, studies willing to
capture the factors explaining these low coverages are
warranted.
Most of bacteria (71.4%) were identified through blood
culture, blood being easily accessible to be sampled. Be-
sides, a great number of infections including localized
ones, have a bacteremic phase during which the bacter-
ium can be picked up through culture of blood [15, 16].
The majority of bacteria identified (77.1%) were Gram
negative, concurring with Diop et al.’s findings [15]. By
contrast, Williams et al. observed a higher proportion of
Gram positive bacteria (41%), Streptococcus pneumoniae
especially [11]. Our observations could be the result of
the introduction of the Prevenar 13® antigen in the
Cameroon EPI since 2011, the antibio-prophylaxis (with
oral penicillin) on which almost all children followed in
the SCD unit and aged 2 to 5–6 years are placed, andthe practice of self-medication with abusive and inappro-
priate intake of antibiotics. This access to non-prescribed
antibiotics may have biased the different specimen culture
results we obtained in this setting. It is therefore under-
standable why only 2 cases of S. pneumoniae infections
were recorded; these two children who presented men-
ingitis had neither received the Prevenar 13® nor the
Pneumo 23® antigens.
The bacterial ecology was dominated by Salmonella sp.
(28.1%), corroborating previous reports [13, 15, 16, 19].
This predominance is related to the digestive translocation
of Salmonellas (ischemic embrittlement) favored by
microvascular occlusions [8, 10, 15, 16]. Many infec-
tions were also caused by Klebsiella pneumoniae
(17.7%), not often found in these proportions according
to previous reports [11, 15, 16]. K. pneumoniae was the
second bacterium responsible for urinary tract infec-
tions (30.8%), in line with results from Asinobi et al.
(18.9%) and Mava et al. (24.6%) [12, 20]. Escherichia
coli was responsible for 10.4% of infections, mainly
urinary tract infections (53.8%) still concurring with the
literature [12, 13, 20].
Acinetobacter sp. was the fourth bacterium reported by
Williams et al., found in 7% of cases [11], hence almost
comparable to the 4.2% we have recorded. Staphylococcus
sp. was responsible for 18.8% of BIs, corroborating previ-
ous studies [13, 19, 21, 22]. These bacteria were mainly
represented by those known to be commensals, hence a
possibility of contaminations. In fact, due to lack of fi-
nances to perform more explorations, it was difficult to
differentiate between real infections caused by these
bacteria (identified through only one bacteriological ex-
ploration) and a simple contamination of the sample
cultured. However, the concerned patients presented an
inflammatory syndrome and got better only after proper
and adapted antibiotherapy, confirming thereby the initial
suspicion. The absence of H. influenzae infections in the
present report may be explained by the introduction (in
2008) of three doses of the Haemophilus influenzae type b
antigen in the Cameroon EPI, notably at 6, 10 and
14 weeks of age, and perhaps abusive use of antibiotics as
self-medication.
We recorded 5 cases of infectious recurrence reflect-
ing the high susceptibility of SCD patients to BIs, driven
by a functional asplenia, a default in complement activa-
tion, micronutrient deficiencies, and mechanical and
genetic factors [8]. Three patients died: one 2 years old
boy who died at 24 h of hospitalization from meningitis
caused by Streptococcus pneumoniae, and a 5 years old
male child at 48 h from a severe sepsis caused by a non-
typhi Salmonella sp. The third case was a female child
of 7 years who was suffering from a severe sepsis with
multifocal sites caused by a non-hospital acquired multi-
resistant Enterobacter cloacae; she was transferred to the
Alima Yanda et al. BMC Infectious Diseases  (2017) 17:211 Page 6 of 7emergency care unit where she died after 3 months of
hospitalization.
Unfortunately, this study presents a number of flaws.
First, the retrospective analysis of this work precluded us
from obtaining all the information necessary, and having
a control group to investigate some factors driving the
occurrence of BIs in our milieu. Second, parents’ financial
constraints and lack of funding impeded the realization of
more bacteriological explorations which could have per-
mitted to depict and confirm more cases of BI; for the
same reasons, only one blood culture (instead of at least
three per patient) was performed for most patients, hence
diminishing considerably our probability of catching up
the causal agent. Moreover, a free access to non-prescribed
antibiotics in our context may have constituted a source of
bias towards our results. Third, our analyses are based only
on known SCD children, in a context where newborns are
not systematically screened for SCD; this could have led to
an underestimation of the real burden of BIs. Fourth, SCD
children were recruited from only one hospital, perhaps
hindering the generalization of results obtained. Nonethe-
less, the study was conducted in a reference hospital with
patients coming from all over the country and the Central
African sub-region. Besides, the study period of almost
3 years permitted to record a great number of cases.Conclusion
This 3-years retrospective analysis permitted to record
96 cases (9.7%) of bacterial infections among SCD children
living in Cameroon. The bacterial ecology was mainly rep-
resented by Salmonella sp. (28.1%), Staphylococcus sp.
(18.8%), Klebsiella pneumoniae (17.7%), Escherichia coli
(10.4%), Enterobacter sp. (5.2%), Streptococcus sp. (4.2%),
Acinetobacter sp. (4.2%), and Serratia sp. (4.2%). Substantial
efforts to vaccinate SCD children after 12 months of age
(when they leave the EPI) and increase the vaccination
coverage in this group of vulnerable children could help to
reduce the burden of BIs in SCD children. Patient’s parents
should be continuously sensitized and educated on the im-
portance of vaccinating their kids, observe the penicillin
antibio-prophylaxis and bring their kids to the hospital as
soon as the temperature rises. Our clinicians must be ad-
equately trained to manage these infections, bearing in
mind that broad spectrum antibiotherapy should be started
without waiting for bacteriological results. On the other
hand, we believe it is high time our Governments think of
subsidizing the management of SCD children for those
parents who cannot pay. Cost-benefit studies are warranted
in this regard.Abbreviations
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